A Study to Evaluate Efficacy and Safety of BAC in Patient With Alzheimer's Disease or Vascular Dementia
Public ClinicalTrials.gov record NCT02886494. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Randomized, Double-Blind, Vehicle-Controlled, Parallel, Phase II Study to Evaluate Efficacy and Safety of BAC in Patient With Alzheimer's Disease or Vascular Dementia
Study identification
- NCT ID
- NCT02886494
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 2
- Lead sponsor
- Charsire Biotechnology Corp.
- Industry
- Enrollment
- 80 participants
Conditions and interventions
Conditions
Interventions
- BAC treatment Drug
- Matched vehicle Drug
Drug
Eligibility (public fields only)
- Age range
- 40 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Nov 30, 2016
- Primary completion
- Oct 31, 2018
- Completion
- Oct 31, 2018
- Last update posted
- Oct 12, 2022
2016 – 2018
United States locations
- U.S. sites
- 10
- U.S. states
- 8
- U.S. cities
- 10
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Clinical Research Consortium | Tempe | Arizona | 85283 | — |
| Woodland International Research Group | Little Rock | Arkansas | 72211 | — |
| Woodland Research Northwest, LLC | Rogers | Arkansas | 72758 | — |
| Pacific Research Network, LLC | San Diego | California | 92103 | — |
| NeuroTrials Research, Inc. | Atlanta | Georgia | 30342 | — |
| The Cognitive and Research Center of NJ | Springfield | New Jersey | 07081 | — |
| Advanced Memory Research Institute of NJ, PC | Toms River | New Jersey | 08755 | — |
| SPRI | Brooklyn | New York | 11235 | — |
| Wake Research Associates | Raleigh | North Carolina | 27612 | — |
| Neurology Diagnostics, Inc. | Dayton | Ohio | 45459 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT02886494, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Oct 12, 2022 · Synced Jun 26, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT02886494 live on ClinicalTrials.gov.